BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1619 related articles for article (PubMed ID: 18086466)

  • 1. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
    Silva C; Fuxe K; Chadi G
    J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF-2 and S100beta immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA-induced partial lesion of the nigrostriatal system.
    Chadi G; Gomide VC
    Cell Biol Int; 2004; 28(12):849-61. PubMed ID: 15566955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial bFGF and S100 immunoreactivities increase in ascending dopamine pathways following striatal 6-OHDA-induced partial lesion of the nigrostriatal system: a sterological analysis.
    Gomide V; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):537-55. PubMed ID: 15809219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.
    Chadi G; Cao Y; Pettersson RF; Fuxe K
    Neuroscience; 1994 Aug; 61(4):891-910. PubMed ID: 7838386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine.
    Rodrigues RW; Gomide VC; Chadi G
    Int J Neurosci; 2004 Feb; 114(2):197-216. PubMed ID: 14702208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2000 Dec; 16(6):781-92. PubMed ID: 11124897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease.
    Claus P; Werner S; Timmer M; Grothe C
    Neurosci Lett; 2004 Apr; 360(3):117-20. PubMed ID: 15082147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
    Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
    J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat.
    Blum M; Wu G; Mudó G; Belluardo N; Andersson K; Agnati LF; Fuxe K
    Neuroscience; 1996 Jan; 70(1):169-77. PubMed ID: 8848122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
    Chadi G; Møller A; Rosén L; Janson AM; Agnati LA; Goldstein M; Ogren SO; Pettersson RF; Fuxe K
    Exp Brain Res; 1993; 97(1):145-58. PubMed ID: 7907549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.
    Kozlowski DA; Miljan EA; Bremer EG; Harrod CG; Gerin C; Connor B; George D; Larson B; Bohn MC
    Brain Res; 2004 Aug; 1016(2):170-81. PubMed ID: 15246853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
    Iczkiewicz J; Rose S; Jenner P
    Exp Neurol; 2007 Sep; 207(1):95-106. PubMed ID: 17643430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
    Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME
    J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats.
    Sarre S; Yuan H; Jonkers N; Van Hemelrijck A; Ebinger G; Michotte Y
    J Neurochem; 2004 Jul; 90(1):29-39. PubMed ID: 15198664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of FGF-2 in neurons and reactive astrocytes of axotomized rat hypoglossal nucleus. A possible therapeutic target for neuroprotection in peripheral nerve pathology.
    de Oliveira GP; Duobles T; Castelucci P; Chadi G
    Acta Histochem; 2010 Nov; 112(6):604-17. PubMed ID: 19665173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.